Applications of continuous glucose monitoring across settings and populations: Report from the 23rd Hong Kong diabetes and cardiovascular risk factors—East meets west symposium
Study context
- Population
- People with T1D and insulin-treated T2D; special groups incl. impaired kidney function and pregnancy
- Outcome
- Applications of CGM across settings and populations
Methodological detailsnarrative review
- Narrative review
Main finding
As reported in the abstract
- Continuous glucose monitoring (CGM) is an integral part of glycaemic management in T1D and insulin-treated T2D
- CGM metrics incl. Time-in-range (TIR), glycaemic variability and hypoglycaemia are strongly endorsed by people with diabetes as impacting daily lives
- Growing consensus on definitions and targets of CGM metrics; increasing studies show correlations between CGM metrics and incident diabetes complications
- UK is one of few countries with clinical pathways integrating CGM into routine T1D care
- People with impaired kidney function and pregnant women may derive additional benefits from CGM
Original publication
Applications of continuous glucose monitoring across settings and populations: Report from the 23rd Hong Kong diabetes and cardiovascular risk factors—East meets west symposium. Diabet Med. Published 7 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →